About the Company
TG BioTech Co. is continuously engaged in research and development to promote healthy aging and longevity.
About the Company
TG BioTech Co. is continuously engaged in research and development to promote healthy aging and longevity.
About the Company
TG BioTech Co. is continuously engaged in research and development to promote healthy aging and longevity.
Company History
2022's ~ NOW
2024
Export Excellence Award for $3 Million in Sales, Selected as a Top Performing Company from Daegu's Star Enterprises
2023
Actiponin® (액티포닌) approved by US FDA as a New Dietary Ingredient (NDI)
2022
Selected as a 'Free Star Company' in Daegu Metropolitan City
2014's ~ 2021's
2021
Actiponin® General Food Functionality Label Approval Obtained
Actiponin® Launched in the Philippines, Thailand, Malaysia
2020
Whole Foods Market, a subsidiary of Amazon, received the Natural Choice Award in the Weight Management category
(AMPK Metabolic Activator by Life Extension USA)
2017
Launching of Actiponin® in the US Market
2014
Actiponin® Launch in Domestic Market
Actiponin® Registered in Japan and China Patents
2013's ~ 2000's
2013
Actiponin® Health Functional Food Individually Recognized Functional Ingredient Certification
(Korean Ministry of Food and Drug Safety)
Actiponin® Registered with US Patent
2012
Actiponin® Anti-Obesity Efficacy Clinical Trial Completed
2009
Actiponin® has been registered as a domestic patent (KR10-0930580).
2007
Development of Body Fat Improvement Substance (Dolwoe Leaf Ethanol Extract Powder, Actiponin®)
2006
YTN News "Scientists Leading the 21st Century" Broadcasted,
Investment Attracted from Korea Development Bank and KDB Capital
2004
Discovery of Obesity Gene
(IDPc; cytosolic NADP-dependent isocitrate dehydrogenase)
2002
Selected as an INNO-BIZ Company and Recognized for Cutting-Edge Technology Excellence
2000
TG Biotech Co., Ltd. was established (Established on March 20, invested by SK, Dong-A Pharmaceutical, etc.)
Company History
2022's ~ NOW
2024
Export Excellence Award for $3 Million in Sales, Selected as a Top Performing Company from Daegu's Star Enterprises
2023
Actiponin® (액티포닌) approved by US FDA as a New Dietary Ingredient (NDI)
2022
Selected as a 'Free Star Company' in Daegu Metropolitan City
2014's ~ 2021's
2021
Actiponin® General Food Functionality Label Approval Obtained
Actiponin® Launched in the Philippines, Thailand, Malaysia
2020
Whole Foods Market, a subsidiary of Amazon, received the Natural Choice Award in the Weight Management category
(AMPK Metabolic Activator by Life Extension USA)
2017
Launching of Actiponin® in the US Market
2014
Actiponin® Launch in Domestic Market
Actiponin® Registered in Japan and China Patents
2013's ~ 2000's
2013
Actiponin® Health Functional Food Individually Recognized Functional Ingredient Certification
(Korean Ministry of Food and Drug Safety)
Actiponin® Registered with US Patent
2012
Actiponin® Anti-Obesity Efficacy Clinical Trial Completed
2009
Actiponin® has been registered as a domestic patent (KR10-0930580).
2007
Development of Body Fat Improvement Substance (Dolwoe Leaf Ethanol Extract Powder, Actiponin®)
2006
YTN News "Scientists Leading the 21st Century" Broadcasted,
Investment Attracted from Korea Development Bank and KDB Capital
2004
Discovery of Obesity Gene
(IDPc; cytosolic NADP-dependent isocitrate dehydrogenase)
2002
Selected as an INNO-BIZ Company and Recognized for Cutting-Edge Technology Excellence
2000
TG Biotech Co., Ltd. was established (Established on March 20, invested by SK, Dong-A Pharmaceutical, etc.)
Company History
2022's ~ NOW
2024
Export Excellence Award for $3 Million in Sales, Selected as a Top Performing Company from Daegu's Star Enterprises
2023
Actiponin® (액티포닌) approved by US FDA as a New Dietary Ingredient (NDI)
2022
Selected as a 'Free Star Company' in Daegu Metropolitan City
2014's ~ 2021's
2021
Actiponin® General Food Functionality Label Approval Obtained
Actiponin® Launched in the Philippines, Thailand, Malaysia
2020
Whole Foods Market, a subsidiary of Amazon, received the Natural Choice Award in the Weight Management category
(AMPK Metabolic Activator by Life Extension USA)
2017
Launching of Actiponin® in the US Market
2014
Actiponin® Launch in Domestic Market
Actiponin® Registered in Japan and China Patents
2013's ~ 2000's
2013
Actiponin® Health Functional Food Individually Recognized Functional Ingredient Certification
(Korean Ministry of Food and Drug Safety)
Actiponin® Registered with US Patent
2012
Actiponin® Anti-Obesity Efficacy Clinical Trial Completed
2009
Actiponin® has been registered as a domestic patent (KR10-0930580).
2007
Development of Body Fat Improvement Substance (Dolwoe Leaf Ethanol Extract Powder, Actiponin®)
2006
YTN News "Scientists Leading the 21st Century" Broadcasted,
Investment Attracted from Korea Development Bank and KDB Capital
2004
Discovery of Obesity Gene
(IDPc; cytosolic NADP-dependent isocitrate dehydrogenase)
2002
Selected as an INNO-BIZ Company and Recognized for Cutting-Edge Technology Excellence
2000
TG Biotech Co., Ltd. was established (Established on March 20, invested by SK, Dong-A Pharmaceutical, etc.)
TG Biotech Co., Ltd.
CEO: Taerin Heo
Head Office: B123, Techno Building, Kyungpook National University, 47, Gyeongdae-ro 17-gil, Buk-gu, Daegu, Republic of Korea
Tel: +82-53-953-0833 | Fax: +82-53-953-0834
© TG Biotech Corporation All Rights Reserved
TG Biotech Co., Ltd.
CEO: Taerin Heo
Head Office: B123, Techno Building, Kyungpook National University, 47, Gyeongdae-ro 17-gil, Buk-gu, Daegu, Republic of Korea
Tel: +82-53-953-0833 | Fax: +82-53-953-0834
© TG Biotech Corporation All Rights Reserved
TG Biotech Co., Ltd.
CEO: Taerin Heo
Head Office: B123, Techno Building, Kyungpook National University, 47, Gyeongdae-ro 17-gil, Buk-gu, Daegu, Republic of Korea
Tel: +82-53-953-0833 | Fax: +82-53-953-0834
© TG Biotech Corporation All Rights Reserved